Skip to content

Dental Scaling and Root Planning Improve Allergies

Effect of Comprehensive Six Months Dental Scaling and Root Planning To Improve Biomolecular Markers of Atopy in Gingivitis Children with House Dust Mite Allergy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN31416107
Enrollment
10
Registered
2018-04-17
Start date
2017-01-31
Completion date
Unknown
Last updated
2020-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis Oral Health Periodontitis

Interventions

Participants are randomly allocated to one of two groups. Those in the intervention group receive a comprehensive 6 months dental scaling and root planning treatment program, as well as standard treat

Sponsors

Faculty of Dental Medicine Universitas Airlangga
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Children aged 6-16 years of any gender and ethnicity 2. Diagnosed with HDM allergies by positive skin-prick test 3. Diagnosed with gingivitis by >2 plaque index according to Silness-Löe criteria 4. High baseline IgE titer (>90 pg/ml), suggesting a positive childhood allergic potency 5. Understand and able to cooperate to the research protocol 6. Parents give voluntary, signed written consent in accordance with our institutional policies

Exclusion criteria

Exclusion criteria: 1. Taking any antihistamines or steroid which commonly interferes with results of skin-prick within one month 2. Previously experienced any immunotherapy procedures 3. Previously experienced dental scaling and root planning within 6 months 4. Presence of low grade fever due to infections rather than gingivitis 5. Recent blood disorders or congenital abnormalities 6. Any medical conditions that may be harmful if involved in this study

Design outcomes

Primary

MeasureTime frame
IgE is measured from a blood sample at baseline and 6 months

Secondary

MeasureTime frame
IgG4 is measured from a blood sample at baseline and 6 months

Countries

Indonesia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 20, 2026